Cargando…
Wound healing with “spray‐on” autologous skin grafting (ReCell) compared with standard care in patients with large diabetes‐related foot wounds: an open‐label randomised controlled trial
There is an urgent need for interventions that improve healing time, prevent amputations and recurrent ulceration in patients with diabetes‐related foot wounds. In this randomised, open‐label trial, participants were randomised to receive an application of non‐cultured autologous skin cells (“spray‐...
Autores principales: | Manning, Laurens, Ferreira, Ivana Bastos, Gittings, Paul, Hiew, Jonathan, Ryan, Erica, Baba, Mendel, Raby, Edward, Carville, Keryln, Norman, Paul E., Davis, Wendy Angela, Wood, Fiona, Hamilton, Emma Jane, Ritter, Jens Carsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874115/ https://www.ncbi.nlm.nih.gov/pubmed/34156758 http://dx.doi.org/10.1111/iwj.13646 |
Ejemplares similares
-
Spray on skin for diabetic foot ulcers: an open label randomised controlled trial
por: Manning, Laurens, et al.
Publicado: (2019) -
Exercise in adults admitted to hospital with diabetes-related foot ulcers: a pilot study of feasibility and safety
por: Aitken, Emily, et al.
Publicado: (2023) -
Australian guideline on wound healing interventions to enhance healing of foot ulcers: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease
por: Chen, Pamela, et al.
Publicado: (2022) -
Availability and service provision of multidisciplinary diabetes foot units in Australia: a cross-sectional survey
por: Vo, Uyen Giao, et al.
Publicado: (2021) -
Experience of ReCell in Skin Cancer Reconstruction
por: Gilleard, Onur, et al.
Publicado: (2013)